Oscar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oscar Health, Inc. on March 24, 2022. The filing serves as a Regulation FD disclosure regarding an upcoming investor event.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of an event rather than a financial results statement.
Material Changes
No material changes to financial results or operations are reported in this document. The filing references previously issued guidance from February 10, 2022, which the company intends to reconfirm.
Guidance, Outlook, and Management Commentary
- Investor Day: The Company will host a virtual investor day conference on March 25, 2022, at 9:00 a.m. Eastern Time.
- Guidance Reconfirmation: Management plans to reconfirm its full-year 2022 guidance as originally issued in the February 10, 2022 press release.
- Strategic Plans: The conference will include forward-looking statements regarding strategic plans, long-term growth targets, and levers to achieve these targets.
- Access: A live webcast will be available via the Company's investor relations website.
Investor Verification Checklist
- Verify the full-year 2022 guidance figures in the February 10, 2022 press release to understand the baseline for the upcoming reconfirmation.
- Review the "Risk Factors" section of the Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as referenced in the cautionary note regarding forward-looking statements.
- Confirm the availability of the investor day presentation materials on the investor relations website prior to the March 25 event.